Regorafenib

Product name:Regorafenib
CAS: 755037-03-7
Molecular Formula: C21H15ClF4N4O3
Molecular weight:482.815
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Regorafenib is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.